Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1958 Feb;37(2):172–184. doi: 10.1172/JCI103596

STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME. II. THE LIPOPROTEINS1,2

David Gitlin 1,2,3, David G Cornwell 1,2,3,3, Doris Nakasato 1,2,3, J L Oncley 1,2,3, Walter L Hughes Jr 1,2,3, Charles A Janeway 1,2,3
PMCID: PMC293074  PMID: 13513748

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. ALADJEM F., GOFMAN J. W., LIEBERMAN M. Immunochemical studies on human plasma lipoproteins. J Exp Med. 1957 Jan 1;105(1):49–67. doi: 10.1084/jem.105.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERSON S. A., YALOW R. S. Chemical and biological alterations induced by irradiation of I 131 labeled human serum albumin. J Clin Invest. 1957 Jan;36(1 Pt 1):44–50. doi: 10.1172/JCI103408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERSON S. A., YALOW R. S., SCHREIBER S. S., POST J. Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest. 1953 Aug;32(8):746–768. doi: 10.1172/JCI102789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DE LALLA O. F., GOFMAN J. W. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal. 1954;1:459–478. doi: 10.1002/9780470110171.ch16. [DOI] [PubMed] [Google Scholar]
  6. GITLIN D., JANEWAY C. A., FARR L. E. Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Albumin, gamma-globulin and iron-binding globulin. J Clin Invest. 1956 Jan;35(1):44–56. doi: 10.1172/JCI103251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GITLIN D. The immunochemical hetero-geneity of human plasma beta-lipoprotein. Science. 1953 May 29;117(3048):591–593. doi: 10.1126/science.117.3048.591. [DOI] [PubMed] [Google Scholar]
  8. GOULD R. G. Lipid metabolism and atherosclerosis. Am J Med. 1951 Aug;11(2):209–227. doi: 10.1016/0002-9343(51)90107-6. [DOI] [PubMed] [Google Scholar]
  9. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HILLYARD L. A., ENTENMAN C., FEINBERG H., CHAIKOFF I. L. Lipide and protein composition of four fractions accounting for total serum lipoproteins. J Biol Chem. 1955 May;214(1):79–90. [PubMed] [Google Scholar]
  11. KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J Biol Chem. 1955 Jul;215(1):15–26. [PubMed] [Google Scholar]
  12. KUNKEL H. G., BEARN A. G. Phospholipid studies of different serum lipoproteins employing P32. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):887–891. doi: 10.3181/00379727-86-21264. [DOI] [PubMed] [Google Scholar]
  13. KUNKEL H. G., TRAUTMAN R. The alpha2 lipoproteins of human serum; correlation of ultracentrifugal and electrophoretic properties. J Clin Invest. 1956 Jun;35(6):641–648. doi: 10.1172/JCI103320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LATTA H. Experimental hypersensitivity in the rabbit; blood and tissue concentrations of foreign proteins labeled with radioactive iodine and injected intravenously. J Immunol. 1951 Jun;66(6):635–652. [PubMed] [Google Scholar]
  15. LEVINE L., KAUFFMAN D. L., BROWN R. K. The antigenic similarity of human low density lipoproteins. J Exp Med. 1955 Aug 1;102(2):105–118. doi: 10.1084/jem.102.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PRESSMAN D., EISEN H. N. The zone of localization of antibodies. V. An attempt to saturate antibody-binding sites in mouse kidney. J Immunol. 1950 Apr;64(4):273–279. [PubMed] [Google Scholar]
  17. ROSENMAN R. H., FRIEDMAN M., BYERS S. O. The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia. J Clin Invest. 1956 May;35(5):522–532. doi: 10.1172/JCI103305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. ROSENMAN R. H., FRIEDMAN M. In vivo studies of the role of albumin in endogenous and heparin-activated lipemia-clearing in nephrotic rats. J Clin Invest. 1957 May;36(5):700–705. doi: 10.1172/JCI103472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Randolph M. L., Ryan R. R. A Slicer for Sampling Liquids. Science. 1950 Nov 3;112(2914):528–528. doi: 10.1126/science.112.2914.528. [DOI] [PubMed] [Google Scholar]
  20. THOMAS E. M., ROSENBLUM A. H., LANDER H. B., FISHER R. Relationships between blood lipid and blood protein levels in the nephrotic syndrome. AMA Am J Dis Child. 1951 Feb;81(2):207–214. doi: 10.1001/archpedi.1951.02040030216003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES